...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: How & who comes up with valuations?

I believe the biotechs others presented on this board had successful Phase 11/111 clinical trials. 

I'm not sure which drugs you are referring to that have been bought out early without any proof of some success.

 

Koo

 

Share
New Message
Please login to post a reply